Transmembrane segment IV contributes a functionally important interface for oligomerization of the Class II G protein-coupled secretin receptor - PubMed (original) (raw)
. 2007 Oct 19;282(42):30363-72.
doi: 10.1074/jbc.M702325200. Epub 2007 Aug 28.
Affiliations
- PMID: 17726027
- DOI: 10.1074/jbc.M702325200
Free article
Transmembrane segment IV contributes a functionally important interface for oligomerization of the Class II G protein-coupled secretin receptor
Kaleeckal G Harikumar et al. J Biol Chem. 2007.
Free article
Abstract
Oligomerization of the Class II G protein-coupled secretin receptor has been reported, but the molecular basis for this and its functional significance have not been determined. In the current work, we have examined the possible contribution of each of the transmembrane (TM) segments of this receptor to its homo-oligomerization, using the method of competitive disruption screening for inhibition of receptor bioluminescence resonance energy transfer signal. TM IV was the only segment that was found to disrupt receptor bioluminescence resonance energy transfer. Evaluation of predicted interhelical and lipid-exposed faces of this TM segment demonstrated that its lipid-exposed face represented the determinant for oligomerization. This was further confirmed by mutagenesis of the intact secretin receptor. Morphological FRET was utilized to demonstrate that secretin receptor oligomerization occurred at the cell surface and that this oligomerization was disrupted by mutating Gly(243) and Ile(247), key residues within the lipid-exposed face of TM IV. Although disruption of the receptor oligomerization interface had no effect on secretin binding parameters, it reduced the ability of secretin to stimulate intracellular cAMP. This supports a clear functional effect of oligomerization of this receptor. Such an effect might be particularly relevant to clinical situations in which this receptor is overexpressed, such as in certain neoplasms.
Similar articles
- Functional importance of a structurally distinct homodimeric complex of the family B G protein-coupled secretin receptor.
Gao F, Harikumar KG, Dong M, Lam PC, Sexton PM, Christopoulos A, Bordner A, Abagyan R, Miller LJ. Gao F, et al. Mol Pharmacol. 2009 Aug;76(2):264-74. doi: 10.1124/mol.109.055756. Epub 2009 May 8. Mol Pharmacol. 2009. PMID: 19429716 Free PMC article. - Use of Cysteine Trapping to Map Spatial Approximations between Residues Contributing to the Helix N-capping Motif of Secretin and Distinct Residues within Each of the Extracellular Loops of Its Receptor.
Dong M, Lam PC, Orry A, Sexton PM, Christopoulos A, Abagyan R, Miller LJ. Dong M, et al. J Biol Chem. 2016 Mar 4;291(10):5172-84. doi: 10.1074/jbc.M115.706010. Epub 2016 Jan 6. J Biol Chem. 2016. PMID: 26740626 Free PMC article. - Fluorescence resonance energy transfer analysis of secretin docking to its receptor: mapping distances between residues distributed throughout the ligand pharmacophore and distinct receptor residues.
Harikumar KG, Lam PC, Dong M, Sexton PM, Abagyan R, Miller LJ. Harikumar KG, et al. J Biol Chem. 2007 Nov 9;282(45):32834-43. doi: 10.1074/jbc.M704563200. Epub 2007 Sep 7. J Biol Chem. 2007. PMID: 17827151 - Structural basis of natural ligand binding and activation of the Class II G-protein-coupled secretin receptor.
Miller LJ, Dong M, Harikumar KG, Gao F. Miller LJ, et al. Biochem Soc Trans. 2007 Aug;35(Pt 4):709-12. doi: 10.1042/BST0350709. Biochem Soc Trans. 2007. PMID: 17635130 Review. - Ligand binding and activation of the secretin receptor, a prototypic family B G protein-coupled receptor.
Miller LJ, Dong M, Harikumar KG. Miller LJ, et al. Br J Pharmacol. 2012 May;166(1):18-26. doi: 10.1111/j.1476-5381.2011.01463.x. Br J Pharmacol. 2012. PMID: 21542831 Free PMC article. Review.
Cited by
- Receptor oligomerization: from early evidence to current understanding in class B GPCRs.
Ng SY, Lee LT, Chow BK. Ng SY, et al. Front Endocrinol (Lausanne). 2013 Jan 4;3:175. doi: 10.3389/fendo.2012.00175. eCollection 2012. Front Endocrinol (Lausanne). 2013. PMID: 23316183 Free PMC article. - Minireview: Signal bias, allosterism, and polymorphic variation at the GLP-1R: implications for drug discovery.
Koole C, Savage EE, Christopoulos A, Miller LJ, Sexton PM, Wootten D. Koole C, et al. Mol Endocrinol. 2013 Aug;27(8):1234-44. doi: 10.1210/me.2013-1116. Epub 2013 Jul 17. Mol Endocrinol. 2013. PMID: 23864649 Free PMC article. Review. - Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans.
Maurya IK, Thota CK, Verma SD, Sharma J, Rawal MK, Ravikumar B, Sen S, Chauhan N, Lynn AM, Chauhan VS, Prasad R. Maurya IK, et al. J Biol Chem. 2013 Jun 7;288(23):16775-16787. doi: 10.1074/jbc.M113.467159. Epub 2013 Apr 16. J Biol Chem. 2013. PMID: 23592791 Free PMC article. Retracted. - Modulation of β-catenin signaling by glucagon receptor activation.
Ke J, Zhang C, Harikumar KG, Zylstra-Diegel CR, Wang L, Mowry LE, Miller LJ, Williams BO, Xu HE. Ke J, et al. PLoS One. 2012;7(3):e33676. doi: 10.1371/journal.pone.0033676. Epub 2012 Mar 16. PLoS One. 2012. PMID: 22438981 Free PMC article. - Novel structural and functional insights into M3 muscarinic receptor dimer/oligomer formation.
Hu J, Hu K, Liu T, Stern MK, Mistry R, Challiss RA, Costanzi S, Wess J. Hu J, et al. J Biol Chem. 2013 Nov 29;288(48):34777-90. doi: 10.1074/jbc.M113.503714. Epub 2013 Oct 16. J Biol Chem. 2013. PMID: 24133207 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources